Event dossier

Trump signs executive order accelerating research into psychedelic drug therapies

President Donald Trump signed an executive Saturday that aims to accelerate research and approval of psychedelic-based therapies for conditions such as PTSD. Grouped from 4 articles across 4 sources.

4 reports4 sourcesApr 18, 2026, 8:35 PM
FilterABC News
Clustered coverageABC News, Al Jazeera, The Guardian, The Straits Times
Coverage timeline4
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

ABC NewsApr 18, 2026, 8:35 PM

Trump signs executive order accelerating research into psychedelic drug therapies

President Donald Trump signed an executive Saturday that aims to accelerate research and approval of psychedelic-based therapies for conditions such as PTSD.

The Straits TimesApr 18, 2026, 2:29 PM

Trump signs order easing restrictions on psychedelic drugs

Psychedelic therapy has gained momentum in recent years, with some studies suggesting benefits of using hallucinogens.

Al JazeeraApr 18, 2026, 5:46 PM

Trump joined by Joe Rogan as he signs order to speed up psychedelic review

Order calls on federal government to relax restrictions on psychedelics, including ibogaine, for potential treatments.

The GuardianApr 18, 2026, 3:03 PM

Trump announces reforms to accelerate access to psychedelic drug treatments

President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaine Donald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs. The president signed an executive order directing the federal Food and Drug Administration (FDA) to expedite review of drugs such as ibogaine, which US military veteran groups have said can help treat post-traumatic stress disorder . Continue reading...

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.